*Integrins in Ovarian Cancer: Survival Pathways, Malignant Ascites and Targeted Photochemistry DOI: http://dx.doi.org/10.5772/intechopen.106725*

with poor prognosis and resistance to chemotherapy in tissue samples from ovarian cancer patients. As a result of these findings, the therapeutic potential of YAP/TAZ inhibition in ovarian cancer has become a topic of recent research [75, 80–82]. In summary, the studies discussed above reveal that Wnt signaling pathway and YAP/ TAZ, which can be activated by integrins, are key regulators in ovarian cancer invasion and drug resistance.
